Stallergenes S.A. (GENP) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 38

Stallergenes S.A. (GENP) - Financial and Strategic SWOT Analysis Review

Summary

Stallergenes S.A. (Stallergenes) is a biopharmaceutical company, engaged in providing treatment for allergy-related respiratory diseases. The company has developed diagnostic tests and products with principal focus on about 150 allergies. The important respiratory diseases for which the company offers treatment include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes provides four kinds of treatment, namely, allergen immunotherapy, injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company operates in Belgium, Austria, France, Czech Republic, Germany, Netherlands, Italy, Slovakia, Spain, Portugal and distributes its products across Australia, North America, Europe, Africa and some parts of Asia. Stallergenes is headquartered in Antony, France.

Stallergenes S.A. Key Recent Developments

May 24, 2011: Stallergenes Inaugurates New Administrative Headquarters In Antony, France
Aug 26, 2010: Stallergenes Reports Net Income Of EUR20.2 Million For H1 2010
Mar 16, 2010: Stallergenes Reports Net Income Of EUR22.2 Million For 2009

This comprehensive SWOT profile of Stallergenes S.A. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Stallergenes S.A. - Key Facts
Stallergenes S.A. - Key Employees
Stallergenes S.A. - Key Employee Biographies
Stallergenes S.A. - Major Products and Services
Stallergenes S.A. - Pharmaceutical Pipeline Products Data
Stallergenes S.A., Pipeline Products by Therapy Area
Stallergenes S.A., Pipeline Products by Development Phase
Stallergenes S.A. - History
Stallergenes S.A. - Company Statement
Stallergenes S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Stallergenes S.A. - Business Description
Stallergenes S.A. - SWOT Analysis
SWOT Analysis - Overview
Stallergenes S.A. - Strengths
Strength - Broad Product Pipeline
Strength - Strong In-house Research Capabilities
Strength - Expanding Profitability Ratios
Weakness - Geographical Concentration: Europe
Weakness - Limited Investor Confidence
Opportunity - Strategic Expansions
Opportunity - Inorganic Growth Strategies
Opportunity - Emerging Markets
Opportunity - Changing Demographics
Threat - Uncertain R&D Outcomes
Threat - Cost Containment Pressures
Threat - Intense Competition
Threat - Industry Consolidation
Stallergenes S.A. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Stallergenes S.A., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Stallergenes S.A., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Stallergenes S.A., Recent Deals Summary
Section 5 – Company’s Recent Developments
May 24, 2011: Stallergenes Inaugurates New Administrative Headquarters In Antony, France
Aug 26, 2010: Stallergenes Reports Net Income Of EUR20.2 Million For H1 2010
Mar 16, 2010: Stallergenes Reports Net Income Of EUR22.2 Million For 2009
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Stallergenes S.A., Key Facts
Stallergenes S.A., Key Employees
Stallergenes S.A., Key Employee Biographies
Stallergenes S.A., Major Products and Services
Stallergenes S.A., Number of Pipeline Products by Therapy Area
Stallergenes S.A., Number of Pipeline Products by Development Stage
Stallergenes S.A., Pipeline Products By Therapy Area and Development Phase
Stallergenes S.A., History
Stallergenes S.A., Other Locations
Stallergenes S.A., Subsidiaries
Stallergenes S.A., Key Competitors
Stallergenes S.A., Ratios based on current share price
Stallergenes S.A., Annual Ratios
Stallergenes S.A., Interim Ratios
Stallergenes S.A., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Stallergenes S.A., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Stallergenes S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Stallergenes S.A., Pipeline Products by Therapy Area
Stallergenes S.A., Pipeline Products by Development Phase
Stallergenes S.A., Performance Chart (2006 - 2010)
Stallergenes S.A., Ratio Charts
Stallergenes S.A., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Stallergenes S.A., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011

Novagali Pharma SA
NicOx SA
Vetoquinol S A
Ipsen S.A.
sanofi-aventis AB
BioAlliance Pharma SA

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• eBay - Strong Execution
• Amazon - Point of Realization in 2013?
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile